Paul Hastings Advises Bank of America and Morgan Stanley on $4.5 Billion Committed Bridge Financing for Vertex’s $10 Billion Acquisition of Crinetics

Paul Hastings LLP is representing Bank of America and Morgan Stanley in providing $4.5 billion committed bridge financing to support Vertex Pharmaceuticals Inc.’s $10 billion acquisition of Crinetics Pharmaceuticals Inc.Global Finance partner Morgan Bale is leading the Paul Hastings team, which includes Global Finance partner Kris Villarreal, Capital Markets partner Jeff Ramsay, M&A partner Steve Camahort and associates Andrew Barondess, Monica Han and Connor Macleod.More details on the transaction can be found here.About Paul HastingsWith widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.Associated Professionals: Morgan Bale Kristopher S. Villarreal Jeff S. Ramsay Steve L. Camahort Andrew M. Barondess Sangyon (Monica) Han Connor MacLeod

Paul Hastings Advises Bank of America and Morgan Stanley on $4.5 Billion Committed Bridge Financing for Vertex’s $10 Billion Acquisition of Crinetics

Source

You might also wanna read

STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more

Inside the legal teams behind Meta's $900 million investment in Kunal Shah's CRED

Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.

LeadsOnTrees Launches VC Fundings & M&A API for Real-Time Investment Data

Chemistry Ventures is raising $500M for its second fund

Comments